loading
前日終値:
$1.65
開ける:
$1.66
24時間の取引高:
1.05M
Relative Volume:
0.41
時価総額:
$17.17M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-22.89%
1か月 パフォーマンス:
-41.29%
6か月 パフォーマンス:
-79.22%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$1.17
$1.6627
1週間の範囲:
Value
$1.17
$2.06
52週間の値動き範囲:
Value
$1.00
$9.55

Scienture Holdings Inc Stock (SCNX) Company Profile

Name
名前
Scienture Holdings Inc
Name
セクター
Healthcare (1166)
Name
電話
(800) 261 0281
Name
住所
2420 BRUNELLO TRACE, LUTZ
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
SCNX's Discussions on Twitter

SCNX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Pharmaceutical Retailers icon
SCNX
Scienture Holdings Inc
1.55 17.17M 0 0 0 0.00
Pharmaceutical Retailers icon
WBA
Walgreens Boots Alliance Inc
11.19 9.64B 147.66B -8.64B -363.00M -10.01
Pharmaceutical Retailers icon
WGRX
Wellgistics Health Inc
3.82 205.18M 0 0 0 0.00
Pharmaceutical Retailers icon
HITI
High Tide Inc
1.97 165.92M 376.07M -22.41M 18.73M -0.298
Pharmaceutical Retailers icon
PETS
Petmed Express Inc
4.19 87.58M 270.52M -6.08M 17.42M -0.2944

Scienture Holdings Inc (SCNX) 最新ニュース

pulisher
Mar 26, 2025

Investors: What’s The Real Deal With Scienture Holdings Inc (NASDAQ: SCNX) - Stocks Register

Mar 26, 2025
pulisher
Mar 25, 2025

SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Scienture Gears Up for Major Product Launch: New CCO and Syneos Health Partnership Signal Growth - StockTitan

Mar 25, 2025
pulisher
Mar 25, 2025

3 Reasons APG is Risky and 1 Stock to Buy Instead - The Globe and Mail

Mar 25, 2025
pulisher
Mar 21, 2025

Scienture Holdings Announces FDA Approval for ArbliTM - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Lucid (LCID): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail

Mar 20, 2025
pulisher
Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Scienture Holdings announces draw on Equity Line of Credit - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Scienture announces draaw on Equity Line of Credit - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

Scienture Holdings Announces Draw on ELOC, Temporarily Suspends Further Draws Until Reaching $10/Share or 30 Trading Days - The Manila Times

Mar 19, 2025
pulisher
Mar 19, 2025

Organovo Announces Reverse Stock Split - The Manila Times

Mar 19, 2025
pulisher
Mar 19, 2025

FDA Approves Revolutionary Liquid Losartan: Scienture's Game-Changing Hypertension Treatment - StockTitan

Mar 19, 2025
pulisher
Mar 18, 2025

Scienture announces U.S. FDA approval of NDA for SCN-102 - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

FDA Approves Losartan Potassium for Reduction in Risk of Stroke - Drug Topics

Mar 18, 2025
pulisher
Mar 18, 2025

What's Going On With Scienture Shares Tuesday? - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

FDA Approves SCN-102, Liquid Oral Suspension Formulation of Losartan - Pharmacy Times

Mar 18, 2025
pulisher
Mar 18, 2025

Pre-Market Momentum: Scienture (SCNX) Stock Soars After FDA Green Light - Stocks Telegraph

Mar 18, 2025
pulisher
Mar 18, 2025

Scienture Says US FDA Approves Oral Liquid Formulation of Hypertension Drug Losartan - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024. - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Breakthrough FDA Approval: First-Ever Liquid Hypertension Drug Targets $1.5B Market - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

Billionaires Ray Dalio and Paul Tudor Jones Are Piling Into a Hard Asset That Has Trounced Nvidia This Year - The Globe and Mail

Mar 18, 2025
pulisher
Mar 18, 2025

Q4 Earnings Outperformers: D.R. Horton (NYSE:DHI) And The Rest Of The Home Builders Stocks - The Globe and Mail

Mar 18, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

4 Quantum Computing Stocks on Watch Today as GTC 2025 Kicks Off - The Globe and Mail

Mar 17, 2025
pulisher
Mar 15, 2025

Scienture Holdings Inc (SCNX) Stock Behavior Isn’t As Predictable As You Think - Stocks Register

Mar 15, 2025
pulisher
Mar 14, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 14, 2025
pulisher
Mar 13, 2025

Scienture Holdings appoints new CFO, stockholders vote at annual meeting By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Scienture Holdings appoints new CFO, stockholders vote at annual meeting - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Scienture Holdings Appoints New CFO Eric Sherb - TipRanks

Mar 13, 2025
pulisher
Mar 12, 2025

Public market insider buying at ATS Corp. (ATS) - The Globe and Mail

Mar 12, 2025
pulisher
Mar 10, 2025

Scienture Holdings Secures Exclusive Naloxone Agreement - TipRanks

Mar 10, 2025
pulisher
Mar 08, 2025

United States shares higher at close of trade; Dow Jones Industrial Average up 0.52% - Investing.com India

Mar 08, 2025
pulisher
Mar 07, 2025

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.52% - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Best Stocks Under $5 Right Now - Benzinga

Mar 07, 2025
pulisher
Mar 06, 2025

Nasdaq Down Over 400 Points; Kroger Posts Upbeat Earnings - Benzinga

Mar 06, 2025
pulisher
Mar 06, 2025

What's Going On With Scienture Stock Thursday? - Benzinga

Mar 06, 2025
pulisher
Mar 06, 2025

Scienture Unit, Summit Biosciences Collaborate to Launch Naloxone Spray for Opioid Overdose Treatment in the US - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Dow Tumbles 1%; US Initial Jobless Claims DeclineAclarion (NASDAQ:ACON), AGM Gr Hldgs (NASDAQ:AGMH) - Benzinga

Mar 06, 2025
pulisher
Mar 06, 2025

Scienture (SCNX) Soars In Pre-Hour Trading After Strategic Business Development - Stocks Telegraph

Mar 06, 2025
pulisher
Mar 06, 2025

SCNX Stock Price and Chart — NASDAQ:SCNX - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

Scienture To Commercially Launch Rezenopy -March 06, 2025 at 08:03 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Scienture Holdings rises on launch of opioid overdose antidote Rezenopy - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

SCIENTURE to commercially launch REZENOPY®, a life-saving - GlobeNewswire

Mar 06, 2025
pulisher
Mar 06, 2025

Can This New High-Strength Naloxone Treatment Transform the $189M Opioid Crisis Market? - StockTitan

Mar 06, 2025
pulisher
Feb 22, 2025

Nova Scotia groups want free Canadian trade as poll shows support in Atlantic region - Yahoo Canada Finance

Feb 22, 2025
pulisher
Feb 21, 2025

Scienture Holdings (FRA:4E4) Preferred Stock : €0.00 Mil (As of Sep. 2024) - GuruFocus.com

Feb 21, 2025
pulisher
Feb 20, 2025

Biotech Stocks Facing FDA Decision In March 2025 - RTTNews

Feb 20, 2025
pulisher
Feb 19, 2025

FDA Accepts New Drug Application for Vatiquinone to Treat Friedreich Ataxia - Drug Topics

Feb 19, 2025

Scienture Holdings Inc (SCNX) 財務データ

Scienture Holdings Inc (SCNX) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
pharmaceutical_retailers SSY
$1.02
price down icon 3.77%
$1.05
price down icon 11.02%
$24.89
price up icon 0.59%
$4.19
price down icon 1.18%
$1.97
price down icon 3.90%
大文字化:     |  ボリューム (24 時間):